Figure 68: CNS
Disorder Therapeutic Market, Multiple Sclerosis, Global Market Drivers and Restraints, 2010-2017 109
The medical-surgical CNS
assesses the nature of the problem and develops a comprehensive plan to get LOS in line with national norms, thus returning the service line to financial viability.
Because the CNS
has a macrophage-inhibiting molecule, the myelin cleanup process doesn't proceed efficiently there, and nerve cell regeneration stalls, asserts Schwartz.
The report begins with an introduction to CNS
Lymphoma Therapeutic Products under Development, Key Players in CNS
Lymphoma Therapeutics, CNS
Lymphoma Pipeline Overview, CNS
Lymphoma Pipeline, CNS
Lymphoma Pipeline Assessment
Hans Thoenen and Martin Schwab of the Max Planck Institute for Psychiatry in Martinsried, West Germany, propose that the CNS
contains substances that inhibit nerve outgrowth.
Summit gathers leading stakeholders with the goal of producing concrete results that shape the future of CNS
Summary GlobalData's clinical trial report, "AIDS - Related Primary CNS
Lymphoma Global Clinical Trials Review, H1, 2014" provides data on the AIDS - Related Primary CNS
Lymphoma clinical trial scenario.
LONDON -- Antipsychotics were the largest CNS
drug class with $24.
Knowledge to help your work and save time, helping your influence Our report strives to help your business research, analyses, and decisions on treatments for debilitating CNS
com/research/1fc188/transdermal_cns_th) has announced the addition of the "Transdermal CNS
Therapeutics: Products, Pipeline Candidates, Markets, Forecasts" report to their offering.
Orphan Diseases Therapeutics in CNS
to 2017 - Novel Agents such as AMR101 and ACR16 to Provide Treatment Options and Boost the Huntington's Disease Segment